Source: FAYETTEVILLE OBSERVER, 11/17/15

President Obama's nominee to lead the Food and Drug Administration defended his record on Tuesday as senators pressed him about rising drug prices, slow approval times for new drugs and his ties to the pharmaceutical industry.

For more of this story, click here.